spasticity | Health Newstrack

Allergan agreed to pay $600 million to US Government

Allergan Resolves United States Government Investigation of Past Sales and Marketing Practices Relating to Certain Therapeutic Uses of BOTOX(R) – Allergan, Inc. (NYSE: AGN) announced that it has reached a resolution with the United States Department of Justice (DOJ) regarding the previously reported Government investigation into Allergan’s past U.S. sales and marketing practices relating to certain therapeutic uses of BOTOX(R) (onabotulinumtoxinA).

Cannabis is beneficial for multiple sclerosis

Study confirms that cannabis is beneficial for multiple sclerosis – Cannabis can reduce spasticity (involuntary muscle tension or contraction) in multiple sclerosis (MS) patients, revealed by researchers in a new study.

Multiple sclerosis treatment from fat stem cells

Stem cells from fat tissue offer hope for Multiple sclerosis MS treatment. – A preliminary study on the use of stem cells obtained from a patient’s own adipose tissue in the treatment of multiple sclerosis (MS) has shown promising results.

Adverse reactions linked to Botox use, warns FDA

Ongoing safety review of Botox, Botox Cosmetic and Myobloc taking place in US. – The U.S. Food and Drug Administration today notified the public that Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B) have been linked in some cases to adverse reactions, including respiratory failure and death, following treatment of a variety of conditions using a wide range of doses.